Gara Jalqabaatti › Sklerosis Baay’ee › Alabama
Qorannoo klinikaalii Sklerosis Baay’ee Alabama keessatti
Qorannoo 8 Sklerosis Baay’ee f Alabama keessatti hirmaatuu jiru.
Magaalota Alabama keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Alabama Neurology Associates, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06782490Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
- University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jira
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07475377A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Birmingham
- TG Therapeutics Investigational Trial Site, Cullman
- TG Therapeutics Investigational Trial Site, Huntsville
- fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- North Central Neurology Associates- Site Number : 8401100, Cullman
- Alabama Neurology Associates- Site Number : 8400115, Homewood
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Alabama Neurology Associates PC, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07225504Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
- University of Alabama at Birmingham Medical Center, Birmingham
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT03759522Care in Multiple Sclerosis (MS)
- University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT07011914Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.